Evidence map›Paper›PMID 37253038›Full record

ArticlePloS one2023

Assessing the heterogeneity in the transmission of infectious diseases from time series of epidemiological data.

Günter Schneckenreither, Lukas Herrmann, Rafael Reisenhofer, Niki Popper, Philipp Grohs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Günter SchneckenreitherInstitute of Information Systems Engineering, TU Wien, Vienna, Austria.ORCID 0000-0002-9217-9399
Lukas HerrmannJohann Radon Institute for Computational and Applied Mathematics, Austrian Academy of Sciences, Linz, Austria.
Rafael ReisenhoferFaculty of Mathematics, University of Vienna, Vienna, Austria.ORCID 0000-0003-1652-2412
Niki PopperInstitute of Information Systems Engineering, TU Wien, Vienna, Austria.ORCID 0000-0003-4615-2774
Philipp GrohsJohann Radon Institute for Computational and Applied Mathematics, Austrian Academy of Sciences, Linz, Austria.
Statistics Austria · ATUniversity of Vienna · ATAustrian Academy of Sciences · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural features and the heterogeneity of disease transmissions play an essential role in the dynamics of epidemic spread. But these aspects can not completely be assessed from aggregate data or macroscopic indicators such as the effective reproduction number. We propose in this paper an index of effective aggregate dispersion (EffDI) that indicates the significance of infection clusters and superspreading events in the progression of outbreaks by carefully measuring the level of relative stochasticity in time series of reported case numbers using a specially crafted statistical model for reproduction. This allows to detect potential transitions from predominantly clustered spreading to a diffusive regime with diminishing significance of singular clusters, which can be a decisive turning point in the progression of outbreaks and relevant in the planning of containment measures. We evaluate EffDI for SARS-CoV-2 case data in different countries and compare the results with a quantifier for the socio-demographic heterogeneity in disease transmissions in a case study to substantiate that EffDI qualifies as a measure for the heterogeneity in transmission dynamics.

Indexed as

Communicable DiseasesCOVID-19Disease OutbreaksHumansSARS-CoV-2Time Factors

Identifiers

PMID37253038
PMCPMC10228818
OpenAlexW4378782824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.